Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain

NeuroImage

Volumn 83, Issue , 2013, Pages 200-209

  D'Arceuil, Helen ^a   Coimbra, Alexandre ^b   Triano, Pamela ^a   Dougherty, Margaret ^a   Mello, Julie ^a   Moseley, Michael ^a   Glover, Gary ^a   Lansberg, Maarten ^a   Blankenberg, Francis ^a  

^a STANFORD UNIVERSITY   (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERUMOXYTOL; MAGNETITE;

ADULT; ARTICLE; BRAIN BLOOD VOLUME; BRAIN MAPPING; CONTROLLED STUDY; CORRELATION ANALYSIS; DEFAULT MODE NETWORK; FEMALE; FOURIER TRANSFORMATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEART; HUMAN; IMAGING SOFTWARE; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RESTING STATE NETWORK; SINGLE DRUG DOSE; STEADY STATE; VISUAL NETWORK; VOLUNTEER; BLOOD VOLUME; BLOOD VOLUME DETERMINATION; BRAIN; BRAIN CIRCULATION; DRUG EFFECTS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PROCEDURES; REFERENCE VALUE; REST; YOUNG ADULT;

BLOOD VOLUME; BLOOD VOLUME DETERMINATION; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; FEMALE; FERROSOFERRIC OXIDE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; REFERENCE VALUES; REST; YOUNG ADULT;

EID: 84880950323     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2013.06.066     Document Type: Article

References (23)

1. Barbier E.L., Lamalle L., Decorps M. Methodology of brain perfusion imaging. J. Magn. Reson. Imaging 2001, 13:496-520.
2. Baumgartner R., Cho W., Coimbra A., Gargano C., Iannone R., Struyk A., Fox R., Wang Z., Zhao F., Williams D., Reese T., Henry B., Petersen E., Chen C., Feng D., Apreleva S., Evelhoch J. Evaluation of a functional MRI assay using a novel USPIO contrast agent (ferumoxytol) in normal healthy volunteers 2012, 2885. International Society for Magnetic Resonance in Medine Melbourne, Australia.
3. Beckmann C.F., DeLuca M., Devlin J.T., Smith S.M. Investigations into resting-state connectivity using independent component analysis. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2005, 360:1001-1013.
4. Birn R.M., Murphy K., Bandettini P.A. The effect of respiration variations on independent component analysis results of resting state functional connectivity. Hum. Brain Mapp. 2008, 29:740-750.
5. Buxton R.B., Uludag K., Dubowitz D.J., Liu T.T. Modeling the hemodynamic response to brain activation. Neuroimage 2004, 23(Suppl. 1):S220-S233.
6. Chang C., Glover G.H. Effects of model-based physiological noise correction on default mode network anti-correlations and correlations. Neuroimage 2009, 47:1448-1459.
7. Damoiseaux J.S., Beckmann C.F., Arigita E.J., Barkhof F., Scheltens P., Stam C.J., Smith S.M., Rombouts S.A. Reduced resting-state brain activity in the "default network" in normal aging. Cereb. Cortex 2008, 18:1856-1864.
8. Ding G., Jiang Q., Li L., Zhang L., Zhang Z., Lu M., Li Q., Gu S., Ewing J., Chopp M. Longitudinal magnetic resonance imaging of sildenafil treatment of embolic stroke in aged rats. Stroke 2011, 42:3537-3541.
9. Dosa E., Tuladhar S., Muldoon L.L., Hamilton B.E., Rooney W.D., Neuwelt E.A. MRI using ferumoxytol improves the visualization of central nervous system vascular malformations. Stroke 2011, 42:1581-1588.
10. Gahramanov S., Muldoon L.L., Li X., Neuwelt E.A. Improved perfusion MR imaging assessment of intracerebral tumor blood volume and antiangiogenic therapy efficacy in a rat model with ferumoxytol. Radiology 2011, 261:796-804.
11. Gahramanov S., Raslan A.M., Muldoon L.L., Hamilton B.E., Rooney W.D., Varallyay C.G., Njus J.M., Haluska M., Neuwelt E.A. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study. Int. J. Radiat. Oncol. Biol. Phys. 2011, 79:514-523.
12. Hayashi T., Noshita N., Sugawara T., Chan P.H. Temporal profile of angiogenesis and expression of related genes in the brain after ischemia. J. Cereb. Blood Flow Metab. 2003, 23:166-180.
13. Ito H., Takahashi K., Hatazawa J., Kim S.G., Kanno I. Changes in human regional cerebral blood flow and cerebral blood volume during visual stimulation measured by positron emission tomography. J. Cereb. Blood Flow Metab. 2001, 21:608-612.
14. Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001, 5:143-156.
15. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
16. Leite F.P., Tsao D., Vanduffel W., Fize D., Sasaki Y., Wald L.L., Dale A.M., Kwong K.K., Orban G.A., Rosen B.R., Tootell R.B., Mandeville J.B. Repeated fMRI using iron oxide contrast agent in awake, behaving macaques at 3Tesla. Neuroimage 2002, 16:283-294.
17. Mandeville J.B. IRON fMRI measurements of CBV and implications for BOLD signal. Neuroimage 2012, 62:1000-1008.
18. Nadler S.B., Hidalgo J.H., Bloch T. Prediction of blood volume in normal human adults. Surgery 1962, 51:224-232.
19. Qiu D., Zaharchuk G., Christen T., Ni W.W., Moseley M.E. Contrast-enhanced functional blood volume imaging (CE-fBVI): enhanced sensitivity for brain activation in humans using the ultrasmall superparamagnetic iron oxide agent ferumoxytol. Neuroimage 2012, 62:1726-1731.
20. Shirer W.R., Ryali S., Rykhlevskaia E., Menon V., Greicius M.D. Decoding subject-driven cognitive states with whole-brain connectivity patterns. Cereb. Cortex 2012, 22:158-165.
21. Silver B., McCarthy S., Lu M., Mitsias P., Russman A.N., Katramados A., Morris D.C., Lewandowski C.A., Chopp M. Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2weeks. J. Stroke Cerebrovasc. Dis. 2009, 18:381-383.
22. Stamatakis E.A., Adapa R.M., Absalom A.R., Menon D.K. Changes in resting neural connectivity during propofol sedation. PLoS One 2010, 5:e14224.
23. Stenger V.A., Poser B., Deng W., Anderson R. Susceptibility artifacts in resting state BOLD fMRI 2012, #625. OHBM.